Home - MedicalLab Management Magazine

Current Issue

Hematology Analyzers Buyer's Guide

Antimicrobial Susceptibility Testing & the Microbiology Lab

with Aaron Odegard, MS, MLS(ASCP)CM, SMCCM Laboratory Quality Coordinator Baptist Health Jacksonville, FL MedicalLab Management recently held a webinar entitled: Antimicrobial Susceptibility Testing and the Microbiology Lab Presented by Aaron K. Odegard, MS, MLS(ASCP)CM, SMCM The following questions were submitted by attendees. The webinar slides and full presentation can be downloaded... Read more

Co-Own Blood Administration Among Laboratory, Nursing, and Providers

Administering blood products is among the most heavily regulated processes in a hospital setting. Issues that arise during blood product transfusion are associated with increased lengths of stay, greater risk of nosocomial infections, and significantly higher costs to the organization. The complexity of this process is compounded by the various perspectives through which blood administration is viewed. Accreditation... Read more

Benefits of Digital Microscopy in Hematology and Urinalysis

with Tyler Radke, MLS(ASCP) Director of Laboratory and Pathology Emplify Health Green Bay, Wisconsin Digital microscopy can help the laboratory improve turnaround times, staff efficiency, and quality control. While lab staff may require an adjustment period (as is often the case with newly established technologies), the training and validation requirements associated with these systems... Read more

Current and Future Use of MALDI-TOF

with Wilson Vientos, MS, MT(ASCP)SM Microbiology/TB Supervisor Connecticut VA Healthcare System Q: How has your microbiology laboratory workflow evolved since you began using MALDI-TOF technology? Wilson Vientos: We have been using MALDI-TOF technology for bacterial identifications (IDs) for over 14 years. In that time, we have performed upgrades in the form of both software updates and... Read more

Quality Testing of Clinical Cellular Therapy Products

Blood cell-based medicines have been used as a standard of therapy to treat or cure blood cancers—including leukemia, lymphoma, and myeloma—and inherited blood disorders since the 1960s. Traditionally, the source of blood cells for these therapies originated either from a related or unrelated tissue-matched donor (allogeneic) or from cells harvested from the patients themselves (autologous).... Read more